These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3191893)

  • 21. Rapid switchover to carbamazepine using pharmacokinetic parameters.
    Kanner AM; Bourgeois BF; Hasegawa H; Hutson P
    Epilepsia; 1998 Feb; 39(2):194-200. PubMed ID: 9578000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
    Mimrod D; Specchio LM; Britzi M; Perucca E; Specchio N; La Neve A; Soback S; Levy RH; Gatti G; Doose DR; Maryanoff BE; Bialer M
    Epilepsia; 2005 Jul; 46(7):1046-54. PubMed ID: 16026556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients.
    Patsalos PN
    Br J Clin Pharmacol; 1990 May; 29(5):574-7. PubMed ID: 2350535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual effects of carbamazepine-phenytoin interaction.
    Zielinski JJ; Haidukewych D
    Ther Drug Monit; 1987; 9(1):21-3. PubMed ID: 3576659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of D-cycloserine on the anticonvulsant activity of phenytoin and carbamazepine against electroconvulsions in mice.
    Wlaź P; Roliński Z; Czuczwar SJ
    Epilepsia; 1996 Jul; 37(7):610-7. PubMed ID: 8681892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting antiepileptic drug pharmacokinetics in community-dwelling elderly.
    Cloyd JC; Marino S; Birnbaum AK
    Int Rev Neurobiol; 2007; 81():201-10. PubMed ID: 17433925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flunarizine of limited value in children with intractable epilepsy.
    Hoppu K; Nergårdh AR; Eriksson AS; Beck O; Forssblad E; Boréus LO
    Pediatr Neurol; 1995 Sep; 13(2):143-7. PubMed ID: 8534279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy.
    Sachdeo RC; Sachdeo SK; Walker SA; Kramer LD; Nayak RK; Doose DR
    Epilepsia; 1996 Aug; 37(8):774-80. PubMed ID: 8764818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of single- and multiple-dose carbamazepine on the pharmacokinetics of diphenylhydantoin.
    Lai ML; Lin TS; Huang JD
    Eur J Clin Pharmacol; 1992; 43(2):201-3. PubMed ID: 1425879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population pharmacokinetics of carbamazepine in adults with epilepsy.
    Graves NM; Brundage RC; Wen Y; Cascino G; So E; Ahman P; Rarick J; Krause S; Leppik IE
    Pharmacotherapy; 1998; 18(2):273-81. PubMed ID: 9545146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.
    Sachdeo RC; Sachdeo SK; Levy RH; Streeter AJ; Bishop FE; Kunze KL; Mather GG; Roskos LK; Shen DD; Thummel KE; Trager WF; Curtin CR; Doose DR; Gisclon LG; Bialer M
    Epilepsia; 2002 Jul; 43(7):691-6. PubMed ID: 12102670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of an individualized fixed-dose clinical trial to test the antiepileptic efficacy of a plasma flunarizine concentration.
    Pledger GW; Treiman DM
    Control Clin Trials; 1991 Dec; 12(6):768-79. PubMed ID: 1665118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children.
    Furlanut M; Montanari G; Bonin P; Casara GL
    J Pediatr; 1985 Mar; 106(3):491-5. PubMed ID: 3973787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of coadministered antiepileptic drugs on serum antiepileptic drug concentrations in epileptic patients -quantitative analysis based on suitable transforming factor].
    Fukuoka N
    Yakugaku Zasshi; 2004 Jul; 124(7):443-50. PubMed ID: 15235228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A limited sampling method for the estimation of flunarizine area under the curve (AUC) and maximum plasma concentration (Cmax).
    Mahmood I; Sahlroot JT
    Biopharm Drug Dispos; 1997 Mar; 18(2):117-26. PubMed ID: 9099448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discontinuation of phenytoin, carbamazepine, and valproate in patients with active epilepsy.
    Duncan JS; Shorvon SD; Trimble MR
    Epilepsia; 1990; 31(3):324-33. PubMed ID: 2111768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
    Graves NM; Holmes GB; Fuerst RH; Leppik IE
    Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy.
    Epilepsia; 1998 Sep; 39(9):952-9. PubMed ID: 9738674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
    Bae EK; Lee J; Shin JW; Moon J; Lee KJ; Shin YW; Kim TJ; Shin D; Jang IJ; Lee SK
    Seizure; 2016 Apr; 37():8-12. PubMed ID: 26908152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors influencing carbamazepine pharmacokinetics in children and adults: population pharmacokinetic analysis.
    Milovanovic JR; Jankovic SM
    Int J Clin Pharmacol Ther; 2011 Jul; 49(7):428-36. PubMed ID: 21726493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.